Trial intelligence / Profile preview

SFOP-OS94: Preoperative Chemotherapy in Children and Adolescents With Osteosarcoma

NCT00180908Phase 3Completed

Sponsor
Gustave Roussy
Start
Jun 1994
Modality
DNA Intercalators/Alkylators, Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of methotrexate, doxorubicin, etoposide, ifosfamide in osteosarcoma (OS), sponsored by Gustave Roussy. Started Jun 1994; status: completed.

02

Drugs

methotrexatedoxorubicinetoposideifosfamide
03

Conditions

osteosarcoma (OS)

Beyond the preview

Go deeper on NCT00180908.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00180908.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call